Nano-X Imaging

Nano-X Imaging Ltd., known commercially as Nanox, is a medical imaging technology company developing digital X-ray systems and AI-powered diagnostic tools designed to improve access to medical imaging globally. The company's flagship hardware product, the Nanox.ARC, is an FDA-cleared digital tomosynthesis imaging system that uses a novel multi-source X-ray architecture to produce three-dimensional radiographic images for clinical screening and diagnostic applications.

The Nanox.ARC employs a cold cathode X-ray source technology that differs from conventional single-source rotating anode systems, enabling a more compact and cost-efficient form factor. The system is designed for point-of-care deployment in facilities that may lack access to traditional large-scale imaging equipment. Complementing its hardware, Nanox develops AI-based image analysis software that applies machine learning algorithms to detect indicators of chronic diseases from radiographic scans, supporting earlier diagnosis and preventive care workflows.

Nanox's approach integrates hardware and software components into an end-to-end imaging and diagnostic platform. The company targets healthcare markets where medical imaging infrastructure remains limited, aiming to expand screening capacity for conditions such as cardiovascular disease, pulmonary disorders and musculoskeletal conditions. Nanox trades on Nasdaq under the ticker NNOX.